AMINO, Polifarma Sign Licensing Agreement

AMINO, Polifarma Sign Licensing Agreement

FRELLSTEDT, Germany--AMINO signed a licensingagreement with Polifarma SpA in Rome for AMINO's use of uridine in nutritionaland pharmaceutical applications worldwide. Uridine has been shown to beeffective in treating neurogenerative disorders, depression, arthritis and more,according to AMINO (www.amino.de). Bothcompanies have studied the use of uridine for many years; the agreement willhave AMINO leading marketing efforts supported by R&D expertise fromPolifarma.